Truvian Health Raises $74M to Bring Blood Testing to Anyone, Anywhere
2024年7月17日 - 9:30PM
ビジネスワイヤ(英語)
- Wittington Ventures and Great Point Ventures lead round
- Shoppers Drug Mart, Canada’s largest retail pharmacy chain,
joins as a commercial partner
- New funding to advance Truvian’s clinical trials to secure FDA
clearance for its blood testing platform
Access to healthcare is a fundamental human right. Yet to this
day, routine blood testing is limited across the globe. Truvian
Health (“Truvian”) is redefining the current global infrastructure
through its novel platform, creating a world where central
laboratory equivalent blood tests are available anywhere you go.
Today, Truvian is announcing an injection of $74 million of capital
to be used in part to secure US Food and Drug Administration (FDA)
clearance for its blood testing platform.
In the United States, approximately 50% of adults skip routine
blood testing because it is overwhelmingly complex and
friction-laden with prolonged turnaround times that result in
delayed medical intervention or missed diagnoses leading to
significant, avoidable costs to the US healthcare system. Truvian's
automated benchtop platform promises to change this by enabling
simple, accurate, and comprehensive routine blood tests to be
performed in clinics, doctor’s offices and pharmacies. Over the
past twelve months, Truvian has presented data from multiple
independent clinical studies demonstrating that results from its
platform are equivalent to those produced in a central laboratory
across a large panel of tests.
The latest funding round is co-led by Wittington Ventures and
Great Point Ventures, with continuing strong support from existing
investors, including DNS Capital, Medical Excellence Capital, Tao
Capital, TYH Capital, and 7wireVentures.
As a part of the round, Shoppers Drug Mart, Canada’s largest
pharmacy, joins Truvian as a commercial partner. “Working with our
government partners, we believe in advancing technology to better
support patient care, including comprehensive blood testing,” said
Jeff Leger, president at Shoppers Drug Mart. “Truvian's novel
platform, combined with the convenience of accessing care in
pharmacy, will be an amazing step forward in making care more
accessible and convenient for patients.”
Late last year, Shoppers Drug Mart led an onsite evaluation of
Truvian which compared results from Truvian’s platform to a
traditional central laboratory. Results between Truvian and the
central laboratory were concordant, emphasizing the potential
utility of Truvian’s solution.
“These new investments and strategic partnerships further
validate our goal to bring convenient, comprehensive testing to
primary care, enabling patients and their doctors to make timely
decisions affecting their health,” said Jay Srinivasan, chief
executive officer of Truvian. “We are on the cusp of delivering
what the world needs to counter today’s non-communicable disease
burden and unsustainable healthcare costs.”
Truvian is the first company to share evidence that demonstrates
a multi-modal platform can achieve clinical performance equivalent
to the central laboratory across a large panel of tests with a
single sample. To date, Truvian’s integrated platform has been
evaluated on more than 50,000 samples across 5,000 donors while
achieving a platform run reliability rate of greater than 98%.
Truvian has also scaled its instrument and consumable manufacturing
capabilities to initiate its clinical trials and early partner
access programs.
To learn more about Truvian’s platform, visit
www.truvianhealth.com
About Truvian
Truvian is a transformational healthcare company bringing
lab-accurate results anywhere you go, enabling patients to engage
healthcare providers to lead healthier lives. With a focus on
making routine blood testing accessible, convenient and
transparent, Truvian is accelerating the transition to a
sustainable healthcare ecosystem through its comprehensive benchtop
solution that delivers timely, actionable results to help stop
disease before it starts. For more information, visit
truvianhealth.com or follow us on LinkedIn and X.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240717480701/en/
Media Contact: Steve Atkinson Spectrum Science (858)
519-2224 satkinson@spectrumscience.com